Corbion Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Corbion ha aumentado sus beneficios a una tasa media anual de 13.3%, mientras que los beneficios de la industria de Chemicals han experimentado un crecimiento de 12.4% anual. Los ingresos han ido creciendo a una tasa media de 11.5% al año. La rentabilidad financiera de Corbion es de 11.5%, y sus márgenes netos son de 5%.

Información clave

13.3%

Tasa de crecimiento de los beneficios

13.2%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals	1.6%
Tasa de crecimiento de los ingresos	11.5%
Rentabilidad financiera	11.5%
Margen neto	5.0%
Próxima actualización de resultados	08 Aug 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Corbion N.V. (AMS:CRBN) Shares Could Be 22% Above Their Intrinsic Value Estimate

Jun 04

Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Apr 21

Corbion (AMS:CRBN) Is Paying Out A Dividend Of €0.56

Mar 10

Is Now An Opportune Moment To Examine Corbion N.V. (AMS:CRBN)?

Feb 22

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Jan 26

Is Corbion (AMS:CRBN) Using Too Much Debt?

Dec 20

Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Nov 24

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Nov 09

Corbion (AMS:CRBN) Might Be Having Difficulty Using Its Capital Effectively

Oct 08

Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Sep 19

A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Aug 23

Is It Time To Consider Buying Corbion N.V. (AMS:CRBN)?

Jul 21

Investors Could Be Concerned With Corbion's (AMS:CRBN) Returns On Capital

Jul 06

Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

May 20

Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

May 17

Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

Apr 28

Corbion (AMS:CRBN) Has Announced A Dividend Of €0.56

Apr 07

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Mar 26

Corbion (AMS:CRBN) Has Affirmed Its Dividend Of €0.56

Feb 27

Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?

Feb 27

At €37.02, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?

Feb 13

A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Jan 26

Here's Why I Think Corbion (AMS:CRBN) Is An Interesting Stock

Dec 22

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Dec 10

Is Corbion N.V. (AMS:CRBN) Worth €40.3 Based On Its Intrinsic Value?

Oct 25

We Think Corbion (AMS:CRBN) Is Taking Some Risk With Its Debt

Sep 21

Corbion (AMS:CRBN) Could Be Struggling To Allocate Capital

Sep 01

I Ran A Stock Scan For Earnings Growth And Corbion (AMS:CRBN) Passed With Ease

Aug 17

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

May 02

Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?

Apr 01

Shareholders Of Corbion (AMS:CRBN) Must Be Happy With Their 143% Total Return

Mar 17

Here's What Corbion N.V.'s (AMS:CRBN) Shareholder Ownership Structure Looks Like

Jan 25

Corbion N.V.'s (AMS:CRBN) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Jan 05

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Corbion. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

ENXTAM:CRBN Ingresos, gastos y beneficios (EUR Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Dec 23	1,444	73	178	46
30 Sep 23	1,476	70	180	47
30 Jun 23	1,509	66	181	49
31 Mar 23	1,483	78	176	48
31 Dec 22	1,458	90	171	47
30 Sep 22	1,350	76	167	46
30 Jun 22	1,243	63	162	46
31 Mar 22	1,157	70	158	44
31 Dec 21	1,071	78	155	43
30 Sep 21	1,040	97	149	41
30 Jun 21	1,010	116	144	40
31 Mar 21	998	95	142	38
31 Dec 20	987	73	140	37
30 Sep 20	992	49	143	35
30 Jun 20	997	24	147	32
31 Mar 20	987	25	147	33
31 Dec 19	976	26	146	35
30 Sep 19	953	37	141	38
30 Jun 19	930	48	135	42
31 Mar 19	914	51	132	41
31 Dec 18	897	54	129	39
30 Sep 18	883	61	128	37
30 Jun 18	869	69	126	35
31 Mar 18	880	77	126	34
31 Dec 17	892	85	126	33
30 Sep 17	905	87	128	32
30 Jun 17	918	89	130	32
31 Mar 17	914	95	128	31
31 Dec 16	911	102	126	31
30 Sep 16	917	103	124	33
30 Jun 16	922	104	122	34
31 Mar 16	920	91	122	33
31 Dec 15	918	78	121	33
30 Sep 15	885	45	119	32
30 Jun 15	851	13	118	31
31 Mar 15	811	-4	119	32
31 Dec 14	770	-21	121	32
30 Sep 14	757	-15	119	30
30 Jun 14	744	-9	116	28
31 Mar 14	744	-3	117	26
31 Dec 13	744	2	117	25
30 Sep 13	746	10	121	24
30 Jun 13	747	18	125	22

Ingresos de calidad: CRBN tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(5%) de CRBN son inferiores a los del año pasado (6.2%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de CRBN han crecido un 13.3% al año en los últimos 5 años.

Acelerando crecimiento: CRBN ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: CRBN tuvo un crecimiento negativo de los beneficios (-19%) durante el año pasado, lo que dificulta la comparación con la media de la industria Chemicals (-19%).

Rentabilidad financiera

Alta ROE: La rentabilidad financiera de CRBN (11.5%) se considera baja.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Corbion Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2023 earnings: EPS exceeds analyst expectations

Corbion N.V. to Report Fiscal Year 2023 Results on Mar 01, 2024

First half 2023 earnings released: EPS: €0.48 (vs €0.88 in 1H 2022)

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

First half 2022 earnings released

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Recent updates

Now 23% overvalued

Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?

Corbion Appoints Masha Vis-Mertens as Chief Human Resources Officer and Member of the Executive Committee as of 1 May 2024

Kingswood Capital Management, L.P. completed the acquisition of Emulsifiers business from Corbion N.V.

Corbion Announces Preliminary Results of New Study from Millennial Salmon Project

Dividend of €0.61 announced

Full year 2023 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 18%

Price target decreased by 9.5% to €22.10

Investor sentiment improves as stock rises 22%

Kingswood Capital Management, L.P. singed a binding agreement to acquire Emulsifiers business from Corbion N.V for $362 million.

Investor Optimism Abounds Corbion N.V. (AMS:CRBN) But Growth Is Lacking

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Corbion N.V. to Report Fiscal Year 2023 Results on Mar 01, 2024

Estimating The Fair Value Of Corbion N.V. (AMS:CRBN)

Price target decreased by 9.7% to €26.33

Consensus EPS estimates fall by 10%, revenue upgraded

Corbion (AMS:CRBN) Has A Somewhat Strained Balance Sheet

First half 2023 earnings released: EPS: €0.48 (vs €0.88 in 1H 2022)

Returns On Capital Signal Tricky Times Ahead For Corbion (AMS:CRBN)

When Should You Buy Corbion N.V. (AMS:CRBN)?

Consensus EPS estimates fall by 26%, revenue upgraded

Price target decreased by 14% to €31.63

New minor risk - Dividend sustainability

Corbion N.V. (AMS:CRBN) Shares Could Be 22% Above Their Intrinsic Value Estimate

Corbion N.V. Approves Dividend for the Year 2022, Payable on 30 May 2023

Upcoming dividend of €0.56 per share at 1.9% yield

Insider recently bought €142k worth of stock

Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Consensus EPS estimates fall by 16%, revenue upgraded

Corbion (AMS:CRBN) Is Paying Out A Dividend Of €0.56

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Now An Opportune Moment To Examine Corbion N.V. (AMS:CRBN)?

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Price target increased to €36.28

Is Corbion (AMS:CRBN) Using Too Much Debt?

Corbion N.V. Appoints Jennifer Lindsey as Chief Marketing and Digital Officer

Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Price target decreased to €33.03

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Corbion (AMS:CRBN) Might Be Having Difficulty Using Its Capital Effectively

Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Now 20% undervalued after recent price drop

A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

First half 2022 earnings released

Investor sentiment improved over the past week

Is It Time To Consider Buying Corbion N.V. (AMS:CRBN)?

Investors Could Be Concerned With Corbion's (AMS:CRBN) Returns On Capital

Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

Corbion N.V. Announces Executive Changes

Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Upcoming dividend of €0.56 per share

Consensus forecasts updated

Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

Price target decreased to €40.82

Corbion (AMS:CRBN) Has Announced A Dividend Of €0.56

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Consensus forecasts updated

Corbion (AMS:CRBN) Has Affirmed Its Dividend Of €0.56

Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Corbion N.V. Proposes Cash Dividend for 2021

At €37.02, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?

A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Here's Why I Think Corbion (AMS:CRBN) Is An Interesting Stock

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Is Corbion N.V. (AMS:CRBN) Worth €40.3 Based On Its Intrinsic Value?

We Think Corbion (AMS:CRBN) Is Taking Some Risk With Its Debt

Corbion (AMS:CRBN) Could Be Struggling To Allocate Capital

Desglose de ingresos y gastos
Beta